Farnesoid X receptor alpha: a molecular link between bile acids and steroid signaling?

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Cellular and Molecular Life Sciences

• Publication date

  2013-06-20

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1007/s00018-013-1387-0PMID 23784309PMCID PMC11113643
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effects of Novel Diarylpentanoid Analogues of Curcumin on Secretory Phospholipase A2, Cyclooxygenases, Lipo‐oxygenase, and Microsomal Prostaglandin E Synthase‐1

  2014cited by this paper
• Cholesterol and male fertility: what about orphans and adopted?

  2013cited by this paper
• Bile acids: from digestion to cancers.

  2013cited by this paper
• Effects of nuclear receptor transactivation on steroid hormone synthesis and gene expression in porcine Leydig cells.

  2013cited by this paper
• The farnesoid X receptor -1G>T polymorphism influences the lipid response to rosuvastatin[S]

  2012cited by this paper
• Effects of diarylpentanoid analogues of curcumin on chemiluminescence and chemotactic activities of phagocytes

  2012cited by this paper
• FXR agonist GW4064 increases plasma glucocorticoid levels in C57BL/6 mice.

  2012cited by this paper
• Synthesis and evaluation of curcumin-related compounds for anticancer activity.

  2012cited by this paper
• Development of FXR, PXR and CAR agonists and antagonists for treatment of liver disorders.

  2012cited by this paper
• Glucocorticoid receptor mediates the gluconeogenic activity of the farnesoid X receptor in the fasting condition

  2012cited by this paper
• Glucocorticoids promote hepatic cholestasis in mice by inhibiting the transcriptional activity of the farnesoid X receptor.

  2012cited by this paper
• Bile Acid Signaling in Fetal Tissues: Implications for Intrahepatic Cholestasis of Pregnancy

  2011cited by this paper
• Bile Acid Metabolism and the Pathogenesis of Type 2 Diabetes

  2011cited by this paper
• Molecular interaction between the glucocorticoid receptor and MAPK signaling pathway: a novel link in modulating the anti-inflammatory role of glucocorticoids.

  2011cited by this paper
• Curcumin-like diarylpentanoid analogues as melanogenesis inhibitors

  2011cited by this paper
• Curcumin analogues as possible anti-proliferative & anti-inflammatory agents.

  2011cited by this paper
• Deciphering the nuclear bile acid receptor FXR paradigm

  2010cited by this paper
• The Bile Acid Sensor FXR Protects against Dyslipidemia and Aortic Plaques Development Induced by the HIV Protease Inhibitor Ritonavir in Mice

  2010cited by this paper
• Synthesis and cytotoxic potential of heterocyclic cyclohexanone analogues of curcumin.

  2010cited by this paper
• Raised hepatic bile acid concentrations during pregnancy in mice are associated with reduced farnesoid X receptor function

  2010cited by this paper
• Genetic polymorphisms in the UDP-glucuronosyltransferase 1A1 (UGT1A1) gene and prostate cancer risk in Caucasian men.

  2010cited by this paper
• Synthesis and anti-inflammatory evaluation of novel mono-carbonyl analogues of curcumin in LPS-stimulated RAW 264.7 macrophages.

  2010cited by this paper
• Upregulation of scavenger receptor class B type I expression by activation of FXR in hepatocyte.

  2010cited by this paper
• Synthesis, characterization and structure-activity relationship of novel N-phosphorylated E,E-3,5-bis(thienylidene)piperid-4-ones.

  2010cited by this paper
• Cytochrome P450 3A gene variation, steroid hormone serum levels and prostate cancer--The Rotterdam Study.

  2010cited by this paper
• Bile acid-activated receptors in the treatment of dyslipidemia and related disorders.

  2010cited by this paper
• Association between farnesoid X receptor expression and cell proliferation in estrogen receptor-positive luminal-like breast cancer from postmenopausal patients

  2009influential reference
• Hypophyseal‐Gonadal Dysfunction in Men with Non‐Alcoholic Liver Cirrhosis

  2009cited by this paper
• Role of bile acids and bile acid receptors in metabolic regulation.

  2009cited by this paper
• Alteration in male reproductive system in experimental cholestasis: roles for opioids and nitric oxide overproduction.

  2009cited by this paper
• Synthesis and biological evaluation of curcumin-like diarylpentanoid analogues for anti-inflammatory, antioxidant and anti-tyrosinase activities.

  2009cited by this paper
• Expression of cytochrome P450 3A4 and its clinical significance in human prostate cancer.

  2009cited by this paper
• Exploration and synthesis of curcumin analogues with improved structural stability both in vitro and in vivo as cytotoxic agents.

  2009cited by this paper
• Immunomodulatory effects of curcumin treatment on murine schistosomiasis mansoni.

  2009cited by this paper
• Farnesoid X Receptor, through the Binding with Steroidogenic Factor 1-responsive Element, Inhibits Aromatase Expression in Tumor Leydig Cells*

  2009cited by this paper
• The farnesoid X receptor regulates transcription of 3beta-hydroxysteroid dehydrogenase type 2 in human adrenal cells.

  2009cited by this paper
• Activators of the farnesoid X receptor negatively regulate androgen glucuronidation in human prostate cancer LNCAP cells.

  2008cited by this paper
• Variation of the gene encoding the nuclear bile salt receptor FXR and gallstone susceptibility in mice and humans.

  2008cited by this paper
• Immunolocalization of farnesoid X receptor (FXR) in mouse tissues using tissue microarray.

  2008cited by this paper
• Male hypogonadism in cirrhosis and after liver transplantation

  2008cited by this paper
• A common polymorphism in the bile acid receptor farnesoid X receptor is associated with decreased hepatic target gene expression.

  2007cited by this paper
• Bioavailability of curcumin: problems and promises.

  2007cited by this paper
• Targeting farnesoid X receptor for liver and metabolic disorders.

  2007cited by this paper
• In vivo imaging of farnesoid X receptor activity reveals the ileum as the primary bile acid signaling tissue.

  2007cited by this paper
• Functional variants of the central bile acid sensor FXR identified in intrahepatic cholestasis of pregnancy.

  2007cited by this paper
• Nuclear receptors in human immune cells: expression and correlations.

  2007cited by this paper
• Human constitutive androstane receptor mediated methotrexate induction of human dehydroepiandrosterone sulfotransferase (hSULT2A1).

  2007cited by this paper
• The small heterodimer partner is a gonadal gatekeeper of sexual maturation in male mice.

  2007cited by this paper
• Farnesol, a mevalonate pathway intermediate, stimulates MCF-7 breast cancer cell growth through farnesoid-X-receptor-mediated estrogen receptor activation

  2007cited by this paper
• The UGT2B17 gene deletion polymorphism and risk of prostate cancer. A case-control study in Caucasians.

  2007cited by this paper
• New insights regarding glucocorticoids, stress and gonadotropin suppression.

  2006cited by this paper
• Corticosterone impairs the mRNA expression and activity of 3β- and 17β-hydroxysteroid dehydrogenases in adult rat Leydig cells

  2006cited by this paper
• Deletion Polymorphism of UDP-Glucuronosyltransferase 2B17 and Risk of Prostate Cancer in African American and Caucasian Men

  2006cited by this paper
• Farnesoid X receptor is essential for normal glucose homeostasis.

  2006cited by this paper
• Corticosterone impairs the mRNA expression and activity of 3beta- and 17beta-hydroxysteroid dehydrogenases in adult rat Leydig cells.

  2006cited by this paper
• Chenodeoxycholic acid-mediated activation of the farnesoid X receptor negatively regulates hydroxysteroid sulfotransferase.

  2006cited by this paper
• FXR, a multipurpose nuclear receptor.

  2006cited by this paper
• Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation

  2006cited by this paper
• Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice.

  2006cited by this paper
• Estrogen Receptor α Mediates 17α-Ethynylestradiol Causing Hepatotoxicity*

  2006cited by this paper
• Aromatase inhibitors as adjuvant treatment of breast cancer.

  2006cited by this paper
• The farnesoid X receptor is expressed in breast cancer and regulates apoptosis and aromatase expression.

  2006cited by this paper
• Bile salt biotransformations by human intestinal bacteria Published, JLR Papers in Press, November 18, 2005.

  2006cited by this paper
• Effects of FXR in foam-cell formation and atherosclerosis development.

  2006cited by this paper
• Low sex hormone-binding globulin, total testosterone, and symptomatic androgen deficiency are associated with development of the metabolic syndrome in nonobese men.

  2006cited by this paper
• Estrogen receptor alpha mediates 17alpha-ethynylestradiol causing hepatotoxicity.

  2006cited by this paper
• Transient impairment of the adaptive response to fasting in FXR‐deficient mice

  2005cited by this paper
• LITHOCHOLIC ACID DECREASES EXPRESSION OF UGT2B7 IN CACO-2 CELLS: A POTENTIAL ROLE FOR A NEGATIVE FARNESOID X RECEPTOR RESPONSE ELEMENT

  2005cited by this paper
• The Farnesoid X receptor: a molecular link between bile acid and lipid and glucose metabolism.

  2005cited by this paper
• Regulation of carbohydrate metabolism by the farnesoid X receptor.

  2005cited by this paper
• Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis.

  2005cited by this paper
• Curcumin‐induced antiproliferative and proapoptotic effects in melanoma cells are associated with suppression of IκB kinase and nuclear factor κB activity and are independent of the B‐Raf/mitogen‐activated/extracellular signal‐regulated protein kinase pathway and the Akt pathway

  2005cited by this paper
• Novel pathways of bile acid metabolism involving CYP3A4.

  2005cited by this paper
• METABOLISM OF 26,26,26,27,27,27-F6-1α,23S,25-TRIHYDROXYVITAMIN D3 BY HUMAN UDP-GLUCURONOSYLTRANSFERASE 1A3*

  2005cited by this paper
• Glucocorticoids Regulate Transcription of the Gene for Phosphoenolpyruvate Carboxykinase in the Liver via an Extended Glucocorticoid Regulatory Unit*

  2005cited by this paper
• Regulation of Human Hepatic Hydroxysteroid Sulfotransferase Gene Expression by the Peroxisome Proliferator-Activated Receptor α Transcription Factor

  2005cited by this paper
• Etiology of hormone receptor-defined breast cancer: a systematic review of the literature.

  2004cited by this paper
• Chemotaxis: signalling the way forward

  2004cited by this paper
• Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c.

  2004cited by this paper
• Bile Acids Regulate Gluconeogenic Gene Expression via Small Heterodimer Partner-mediated Repression of Hepatocyte Nuclear Factor 4 and Foxo1*

  2004cited by this paper
• Cell biology of Leydig cells in the testis.

  2004cited by this paper
• Metabolic inactivation of estrogens in breast tissue by UDP-glucuronosyltransferase enzymes: an overview

  2004cited by this paper
• Expression and activation of the farnesoid X receptor in the vasculature.

  2004cited by this paper
• Prostate cancer and polymorphism D85Y in gene for dihydrotestosterone degrading enzyme UGT2B15: Frequency of DD homozygotes increases with Gleason Score

  2004cited by this paper
• La fonction biliaire et sa régulation

  2004cited by this paper
• Effect of chenodeoxycholic acid on 11beta-hydroxysteroid dehydrogenase in various target tissues.

  2004cited by this paper
• Regulation of CYP3A4 by the bile acid receptor FXR: evidence for functional binding sites in the CYP3A4 gene.

  2004cited by this paper
• Inactivation of the glucocorticoid receptor in hepatocytes leads to fasting hypoglycemia and ameliorates hyperglycemia in streptozotocin-induced diabetes mellitus.

  2004cited by this paper
• Paraneoplastic cholestasis associated with prostate carcinoma.

  2004cited by this paper
• Selective estrogen receptor modulation: concept and consequences in cancer.

  2004cited by this paper
• [Biliary function and its regulation].

  2004cited by this paper
• Structure-activity relationship of bile acids and bile acid analogs in regard to FXR activation Published, JLR Papers in Press, September 16, 2003. DOI 10.1194/jlr.M300215-JLR200

  2004cited by this paper
• Bile acid derivatives as ligands of the farnesoid X receptor. Synthesis, evaluation, and structure-activity relationship of a series of body and side chain modified analogues of chenodeoxycholic acid.

  2004cited by this paper
• Six novel UDP-glucuronosyltransferase (UGT1A3) polymorphisms with varying activity

  2004cited by this paper
• Protective Role of Hydroxysteroid Sulfotransferase in Lithocholic Acid-induced Liver Toxicity*

  2003cited by this paper
• Inactivation of androgens by UDP-glucuronosyltransferase enzymes in humans.

  2003cited by this paper
• Peroxisome Proliferator-activated Receptor α Induces Hepatic Expression of the Human Bile Acid Glucuronidating UDP-glucuronosyltransferase 2B4 Enzyme*

  2003cited by this paper
• Human uridine diphosphate-glucuronosyltransferase UGT2B7 conjugates mineralocorticoid and glucocorticoid metabolites.

  2003cited by this paper
• A chemical, genetic, and structural analysis of the nuclear bile acid receptor FXR.

  2003cited by this paper
• Natural Structural Variants of the Nuclear Receptor Farnesoid X Receptor Affect Transcriptional Activation*

  2003cited by this paper

• Farnesol, the farnesol pathway, and the immune-gut-brain axis.

  2026cites this paper
• Discovery of Fluorescent Probe ABDS-2 for Farnesoid X Receptor Modulator Characterization and Cell-Based Imaging.

  2025cites this paper
• Exercise reshapes gut microbiota to ameliorate core symptoms in PCOS: molecular mechanisms and therapeutic implications

  2025cites this paper
• Bile acids target an exposed cavity in the glucocorticoid receptor modulating receptor self-assembly, chromatin binding and transcriptional activity

  2025cites this paper
• Severe hyperlipidemia associated with drug-induced cholestatic liver disease: A case report

  2025cites this paper
• Microbial enzymes in lipid metabolism: unveiling the key players in health and disease

  2024cites this paper
• Mechanisms of probiotic modulation of ovarian sex hormone production and metabolism: a review.

  2024cites this paper
• Signalling cognition: the gut microbiota and hypothalamic-pituitary-adrenal axis

  2023cites this paper
• Recent advances on FXR-targeting therapeutics.

  2022cites this paper
• Metabolic profile predicts incident cancer: A large-scale population study in the UK Biobank.

  2022cites this paper
• FXR in liver physiology: Multiple faces to regulate liver metabolism.

  2021cites this paper
• New perspectives on PPAR, VDR and FXRα as new actors in testicular pathophysiology.

  2020cites this paper
• Farnesoid X receptor alpha (FXRα) is a critical actor of the development and pathologies of the male reproductive system

  2019cites this paper
• Bile acids and glucocorticoid metabolism in health and disease.

  2019cites this paper
• Emodin Rescues Intrahepatic Cholestasis via Stimulating FXR/BSEP Pathway in Promoting the Canalicular Export of Accumulated Bile

  2019cites this paper
• Fxralpha gene is a target gene of hCG signaling pathway and represses hCG induced steroidogenesis.

  2019cites this paper
• Crosstalk between BPA and FXRα Signaling Pathways Lead to Alterations of Undifferentiated Germ Cell Homeostasis and Male Fertility Disorders

  2018cites this paper
• The Bile Acid Nuclear Receptor FXRα Is a Critical Regulator of Mouse Germ Cell Fate

  2017cites this paper
• Metabolomics analysis of liver reveals profile disruption in bovines upon steroid treatment

  2017cites this paper
• Plasma metabolomic profile varies with glucocorticoid dose in patients with congenital adrenal hyperplasia

  2017cites this paper
• Dietary fat and gut microbiota interactions determine diet-induced obesity in mice

  2016cites this paper
• Bile Acids as Novel Pharmacological Agents: The Interplay Between Gene Polymorphisms, Epigenetic Factors and Drug Response.

  2016cites this paper
• Beneficial effect of farnesoid X receptor activation on metabolism in a diabetic rat model.

  2016cites this paper
• Une approche moléculaire pour mieux comprendre l'infertilité chez la vache laitière

  2016cites this paper
• Bile acid-FXRα pathways regulate male sexual maturation in mice

  2016cites this paper
• Evaluation and identification of dioxin exposure biomarkers in human urine by high-resolution metabolomics, multivariate analysis and in vitro synthesis.

  2016cites this paper
• New insights into the androgen biotransformation in prostate cancer: A regulatory network among androgen, androgen receptors and UGTs.

  2016cites this paper
• Etude du rôle du récepteur nucléaire FXRα dans la physiologie et la physiopathologie testiculaire

  2015cites this paper
• Bile acid signaling through farnesoid X and TGR5 receptors in hepatobiliary and intestinal diseases.

  2015cites this paper
• Bile Acid Alters Male Mouse Fertility in Metabolic Syndrome Context

  2015cites this paper
• Cooperative behavior of the nuclear receptor superfamily and its deregulation in prostate cancer.

  2014cites this paper
• Farnesoid X receptor immunolocalization in reproductive tissues of adult female rabbits.

  2014cites this paper
• Effect of simvastatin on the expression of farnesoid X receptor in diabetic animal models of altered glucose homeostasis

  2014cites this paper
• Differential abundance of IGF1, bile acids, and the genes involved in their signaling in the dominant follicle microenvironment of lactating cows and nulliparous heifers.

  2014cites this paper
• World Journal of Hepatology

  year unknowncites this paper